An exploratory study of the effects of imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to timothy grass pollen-an exploratory study of c-kit inhibition in allergic respiratory diseases
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Imatinib (Primary)
- Indications Seasonal allergic rhinitis
- Focus Pharmacodynamics
- Sponsors Novartis
- 21 Jun 2007 Status change from recruiting to in progress
- 16 Feb 2007 New trial record.